Immuneering Corp (IMRX)
2.17
+0.06
(+2.84%)
USD |
NASDAQ |
Nov 22, 10:39
Immuneering Shareholders Equity (Quarterly): 57.72M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 57.72M |
| June 30, 2024 | 66.31M |
| March 31, 2024 | 78.72M |
| December 31, 2023 | 90.58M |
| September 30, 2023 | 104.02M |
| June 30, 2023 | 115.10M |
| March 31, 2023 | 97.79M |
| December 31, 2022 | 109.85M |
| Date | Value |
|---|---|
| September 30, 2022 | 121.89M |
| June 30, 2022 | 133.59M |
| March 31, 2022 | 144.06M |
| December 31, 2021 | 155.98M |
| September 30, 2021 | 158.29M |
| June 30, 2021 | -35.19M |
| March 31, 2021 | 29.58M |
| December 31, 2020 | -22.48M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-35.19M
Minimum
Jun 2021
158.29M
Maximum
Sep 2021
87.86M
Average
100.90M
Median
Shareholders Equity (Quarterly) Benchmarks
| Singular Genomics Systems Inc | 123.25M |
| Biomarin Pharmaceutical Inc | 5.413B |
| Integra Lifesciences Holdings Corp | 1.522B |
| Eton Pharmaceuticals Inc | 15.98M |
| Tenon Medical Inc | 8.191M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 68.56M |
| Total Liabilities (Quarterly) | 10.84M |